Delivery Order W91YU015D0010-W81K0219F0289
Award Date
10/1/19
Potential Completion Date
9/30/20
Potential Value
$659K
Federal Agency
Medical Command
Awardee
Gen-Probe Incorporated
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tacoma, WA 98431, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded Gen-Probe Incorporated, a medical diagnostics company, a $330,000.00 firm fixed price purchase order for the PANTHER INSTRUMENT SYSTEM. This contract is not set aside and is related to the Coronavirus COVID-19 national interest action. Gen-Probe Incorporated has previously provided a variety of medical testing systems and assays, including for infectious diseases, to federal agencies such as the Defense Health Agency, Department of Veterans...
This federal contract award, valued at $1,265,955.00, was issued by the United States Army Medical Command (MEDCOM) to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of APTIMA COMBO 2, 250-TEST KIT, PANTHER systems. The contract is a firm fixed-price purchase order with a completion date of September 30, 2018. Gen-Probe Incorporated is a prime contractor that has held numerous contracts with defense and civilian agencies, primarily supplying testing kits, reagents,...
This federal contract award is for a minimum guarantee delivery order with a firm fixed price of $456,519.00, issued by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company. The award does not have a set-aside designation. Through this contract, Gen-Probe Incorporated will provide a variety of goods and services, including APTIMA combo assay test kits for chlamydia and gonorrhea, APTIMA HIV-1 and hepatitis C virus tests, PANTHER FUSION systems and...
This federal contract award, valued at $25,000.00, was issued by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of PANTHER COVID-19 testing supplies. The contract is a purchase order with a firm fixed price and does not have a set-aside designation. Gen-Probe Incorporated is a key supplier of molecular diagnostic testing systems, assays, and related products and services to various federal agencies, including the Department of Defense,...
This is a firm fixed-price delivery order contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for PANTHER EQUIPMENT AND TEST KITS. The potential value of the contract is $539,000.00. There was no set-aside designation used for this award. Gen-Probe Incorporated has provided a variety of medical testing products and services to federal agencies in the past, including APTIMA assays for infectious diseases, PANTHER FUSION systems,...
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Gen-Probe Incorporated, a medical diagnostics company. The $323,825.00 Firm Fixed Price delivery order is for APTIMA COMBO 2, 250-TEST KIT, PANTHER products, with an ultimate completion date of October 29, 2015. This award was not set aside for any specific business type. Gen-Probe Incorporated is a key supplier of molecular diagnostic testing systems, assays, and...
This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, is for the delivery of PANTHER FUSION SARS-COV2 ASSAY PPR SOLUTION (test kits) and DNA/RNA ENZYME CARTRIDGE (reagent) kits in support of the COVID-19 response. The $1,800,000.00 firm fixed-price delivery order was issued by the Medical Command (MEDCOM) of the U.S. Department of the Army. The contract has no set-aside designation. Gen-Probe, a large specialized supplier in molecular diagnostics, has held...
This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, was issued by the Defense Health Agency. The $552,691.20 firm fixed-price delivery order is for the APTIMA SARS-CoV-2 ASSAY, a COVID-19 testing kit under the Emergency Use Authorization (EUA). The contract has no set-aside designation and is scheduled for completion by September 30, 2022. Gen-Probe Incorporated holds several Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with...
This federal contract was awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for the provision of nucleic acid reagents and associated PANTHER and TIGRIS instruments. The $223,801.32 firm-fixed-price purchase order does not have a set-aside designation. Gen-Probe has previously supplied a range of molecular diagnostic testing systems, assays, and COVID-19 related products to federal agencies including the Defense Health Agency,...
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Gen-Probe Incorporated, a medical diagnostics company. The $311,712.50 Firm Fixed Price Delivery Order is for APTIMA COMBO 2, 250-TEST KIT, PANTHER test kits. The contract does not have a set-aside designation. Gen-Probe is a key supplier of molecular diagnostic testing systems, assays, and related products and services to the U.S. federal government, including the...